{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:09:33Z","timestamp":1777928973193,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Med Screen"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>Many factors need to be considered when planning and managing a screening programme for the early detection of cervical cancer (CC). A non-systematic international review of the organisation of CC screening using high-risk human papillomavirus (HPV-HR) testing, aimed at identifying the organisational methods of these programmes, was conducted with a view to supporting the future of the French system in the context of the transition to HPV-HR testing. In countries where HPV testing has been implemented or planned, the initial reflection process has provided an opportunity to rethink the previous (cytological) screening organisation. Despite considerable differences between countries, a nationally or regionally centralised organisational model appears to be the preferred option in most countries. This model is based on a national\/regional structure tasked with all invitations, reminders, follow-up and coordination, centralised laboratories integrating both biology and pathology laboratories, and a unified information system integrated with routine health management tools used by health practitioners and nurses. Besides quality considerations, grouped purchasing makes it possible to implement a public procurement policy that includes price negotiations with suppliers. Discussions around the introduction of HPV testing have resulted in most countries reviewing or creating information systems and quality assurance processes. While the WHO seems to recommend the systematic use of vaginal self-sampling, very few countries have considered this option. More and more countries are planning to implement vaginal self-sampling, but no clear organisational model has emerged from the countries where it has been implemented to date.<\/jats:p>","DOI":"10.1177\/09691413231158932","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T03:22:58Z","timestamp":1679973778000},"page":"113-119","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing"],"prefix":"10.1177","volume":"30","author":[{"given":"Agathe","family":"Marchadier","sequence":"first","affiliation":[{"name":"Institut National du Cancer, Boulogne Billancourt, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4201-4032","authenticated-orcid":false,"given":"Laura","family":"Bezannier","sequence":"additional","affiliation":[{"name":"Cemka, Bourg-la-Reine, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0313-6232","authenticated-orcid":false,"given":"St\u00e9phanie","family":"Barr\u00e9-Pierrel","sequence":"additional","affiliation":[{"name":"Institut National du Cancer, Boulogne Billancourt, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Manceau","sequence":"additional","affiliation":[{"name":"PwC Advisory - Healthcare & Pharmaceuticals Life-Sciences, Neuilly-sur-Seine, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"A Abadie","sequence":"additional","affiliation":[{"name":"PwC Advisory - Healthcare & Pharmaceuticals Life-Sciences, Neuilly-sur-Seine, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Detournay","sequence":"additional","affiliation":[{"name":"Cemka, Bourg-la-Reine, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"bibr1-09691413231158932","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Evaluation of human papillomavirus (HPV) tests for primary screening of precancerous and cancerous lesions of the cervix and the role of p16\/Ki67 dual immunostaining. https:\/\/www.has-sante.fr\/jcms\/c_2806160\/en\/evaluation-of-human-papillomavirus-hpv-tests-for-primary-screening-of-precancerous-and-cancerous-lesions-of-the-cervix-and-the-role-of-p16\/ki67-dual-immunostaining (accessed 18 July 2022)."},{"key":"bibr2-09691413231158932","unstructured":"World Health Organization. WHO guideline on self-care interventions for health and well-being. Geneva: World Health Organization, https:\/\/apps.who.int\/iris\/handle\/10665\/342741 (2021, accessed 18 July 2022)."},{"key":"bibr3-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2016.12.040"},{"key":"bibr4-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-17-0534"},{"key":"bibr5-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.09.006"},{"key":"bibr6-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.12.021"},{"key":"bibr7-09691413231158932","doi-asserted-by":"publisher","DOI":"10.17061\/phrp2921914"},{"key":"bibr8-09691413231158932","unstructured":"Australian Government Dept of Health and Aged Care. The requirements for laboratories reporting tests for the National Cervical Screening Program (Second Edition 2019). https:\/\/www1.health.gov.au\/internet\/main\/publishing.nsf\/Content\/npaac-cervical-screening (accessed 18 July 2022)."},{"key":"bibr9-09691413231158932","unstructured":"Australian Government Dept of Health and Aged Care. National Cervical Screening Program \u2013 Understanding the National Cervical Screening Program Management Pathway. https:\/\/www.health.gov.au\/resources\/publications\/national-cervical-screening-program-understanding-the-national-cervical-screening-program-management-pathway (2019, accessed 18 July 2022)."},{"key":"bibr10-09691413231158932","unstructured":"Australian Government Dept of Health and Aged Care. Providing cervical screening. https:\/\/www.health.gov.au\/initiatives-and-programs\/national-cervical-screening-program\/providing-cervical-screening (2019, accessed 18 July 2022)."},{"key":"bibr11-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2017.1355110"},{"key":"bibr12-09691413231158932","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S9908"},{"key":"bibr13-09691413231158932","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S99509"},{"key":"bibr14-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0480"},{"key":"bibr15-09691413231158932","unstructured":"Sundhedsstyrelsen. Kan screening for livmoderhals&shy;kr\u00e6ft g\u00f8res endnu bedre? https:\/\/www.sst.dk\/da\/nyheder\/2018\/kan-screening-for-livmoderhalskraeft-goeres-endnu-bedre (accessed 18 July 2022)."},{"key":"bibr16-09691413231158932","unstructured":"Gemeinsamer Bundesausschuss. Richtlinie f\u00fcr organisierte Krebsfr\u00fcherkennungsprogramme. https:\/\/www.g-ba.de\/richtlinien\/104\/ (accessed 18 July 2022)."},{"key":"bibr17-09691413231158932","unstructured":"Institut f\u00fcr Qualit\u00e4t und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). [P15-02] Einladungsschreiben und Entscheidungshilfe zum Zervixkarzinom-Screening. https:\/\/www.iqwig.de\/projekte\/p15-02.html (accessed 18 July 2022)."},{"key":"bibr18-09691413231158932","unstructured":"Krebsforschungszentrum K Deutsches. Geb\u00e4rmutterhalskrebs-Fr\u00fcherkennung. https:\/\/www.krebsinformationsdienst.de\/tumorarten\/gebaermutterhalskrebs\/frueherkennung.php (accessed 18 July 2022)."},{"key":"bibr19-09691413231158932","first-page":"116","volume":"41","author":"Di Stefano F","year":"2017","journal-title":"Epidemiol Prev"},{"key":"bibr20-09691413231158932","unstructured":"RIVM. Framework for the Execution of Cervical Cancer Population Screening. https:\/\/www.rivm.nl\/documenten\/framework-for-execution-of-cervical-cancer-population-screening (accessed 18 July 2022)."},{"key":"bibr21-09691413231158932","unstructured":"Nationella Kvalitetsregistret f\u00f6r Cervixcancerprevention. https:\/\/nkcx.se\/ (accessed 18 July 2022)."},{"key":"bibr22-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2019.03.002"},{"key":"bibr23-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31212"},{"key":"bibr24-09691413231158932","unstructured":"GOV.UK. Cervical screening: programme overview. https:\/\/www.gov.uk\/guidance\/cervical-screening-programme-overview (accessed 18 July 2022)."},{"key":"bibr25-09691413231158932","unstructured":"GOV.UK. Cervical screening: guidance for call and recall administration best practice. https:\/\/www.gov.uk\/government\/publications\/cervical-screening-call-and-recall-administration-best-practice\/cervical-screening-call-and-recall (accessed 18 July 2022)."},{"key":"bibr26-09691413231158932","unstructured":"GOV.UK. Cervical screening quality assurance: local visit reports. https:\/\/www.gov.uk\/government\/collections\/cervical-screening-quality-assurance-local-visit-reports (accessed 18 July 2022)."},{"key":"bibr27-09691413231158932","unstructured":"NHS Screening Programmes. E-learning for healthcare. https:\/\/www.e-lfh.org.uk\/programmes\/nhs-screening-programmes\/ (accessed 18 July 2022)."},{"key":"bibr28-09691413231158932","unstructured":"nhs.uk. NHS long term plan. https:\/\/www.longtermplan.nhs.uk (accessed 18 July 2022)."},{"key":"bibr29-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1111\/cyt.12320"},{"key":"bibr30-09691413231158932","unstructured":"Public Health Wales. CSW programme standards and management. https:\/\/phw.nhs.wales\/services-and-teams\/cervical-screening-wales\/csw-programme-standards-and-management\/ (accessed 18 July 2022)."},{"key":"bibr31-09691413231158932","unstructured":"GOV.WALES. Written statement: cervical screening (11 April 2019). https:\/\/www.gov.wales\/written-statement-cervical-screening (accessed 18 July 2022)."},{"key":"bibr32-09691413231158932","unstructured":"Suomen Sy\u00f6p\u00e4rekisteri [Finnish Cancer Registry]. Cervical cancer screening. https:\/\/cancerregistry.fi\/screening\/cervical-cancer-screening\/ (accessed 18 July 2022)."},{"key":"bibr33-09691413231158932","unstructured":"Finnish Medical Society Duodecim. Lis\u00e4tietoa uusista n\u00e4ytteenottotekniikoista [More information about new sampling techniques]. https:\/\/www.kaypahoito.fi\/nix02431 (accessed 18 July 2022)."},{"key":"bibr34-09691413231158932","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-015-0261-7"},{"key":"bibr35-09691413231158932","unstructured":"Cancer Screening Fact Sheet. https:\/\/nordscreen.org\/wp-content\/uploads\/2017\/04\/Cervix-Fact-Sheet-Finland-2016.pdf (accessed 18 July 2022)."},{"key":"bibr36-09691413231158932","unstructured":"Cervical Check, Ireland. Taking a cervical screening test. https:\/\/www.cervicalcheck.ie\/cervical-screening-test-guidelines-and-forms\/taking-a-cervical-screening-test.16276.html (accessed 18 July 2022)."},{"key":"bibr37-09691413231158932","unstructured":"FHI, Norway. Diagnostikk - Nasjonalt handlingsprogram med retningslinjer for gynekologisk kreft. 28.06.2021, https:\/\/www.helsebiblioteket.no\/retningslinjer\/gynekologisk-kreft\/premaligne-lidelser-i-cervix-uteri\/diagnostikk (accessed 18 July 2022)."},{"key":"bibr38-09691413231158932","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2018-0036"}],"container-title":["Journal of Medical Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413231158932","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09691413231158932","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413231158932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:25:39Z","timestamp":1777677939000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09691413231158932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1177\/09691413231158932"],"URL":"https:\/\/doi.org\/10.1177\/09691413231158932","relation":{},"ISSN":["0969-1413","1475-5793"],"issn-type":[{"value":"0969-1413","type":"print"},{"value":"1475-5793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]}}}